SEC Tracker
Get the app

Karyopharm Therapeutics KPTI

Karyopharm Therapeutics: quarterly report for the quarter ended Jun 30, 2023

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q
Exhibit 10.4
Material contract
Exhibit 10.5
Material contract

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Karyopharm Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Abvc Biopharma ABVC public float $37M, Jun 30, 2025
  2. BriaCell Therapeutics BCTX public float $37M, Jan 30, 2026
  3. Annovis Bio ANVS public float $36M, Jun 30, 2025
  4. Atara Biotherapeutics ATRA public float $39M, Jun 30, 2025
  5. Grace Therapeutics GRCE public float $35M, Sep 30, 2025